NEW YORK, March 19, 2023 /PRNewswire/ — Meet the future of sun care. After three years of development, the brand’s revolutionary approach to skin barrier health is going to shake up the SPF category. BYOMA’s most anticipated formula yet was informed and inspired by the brand’s connected…
Month: March 2023
BEIJING, March 19, 2023 /PRNewswire/ — Since it began operating in December 2021, the China-Laos Railway, a flagship Belt and Road cooperation project, has brought great benefits to the people of Laos and opened up a new path for the nation’s development and prosperity. “Laos and China…
BEIJING, March 19, 2023 /PRNewswire/ — Since it began operating in December 2021, the China-Laos Railway, a flagship Belt and Road cooperation project, has brought great benefits to the people of Laos and opened up a new path for the nation’s development and prosperity. “Laos and China…
NEW YORK, March 18, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Norfolk Southern Corporation (NYSE: NSC) between October 28, 2020 and March 3, 2023, both dates…
SEOUL, South Korea, March 18, 2023 /PRNewswire/ — LG Display, the world’s leading innovator of display technologies, announced today that its 65-inch OLED TV panel earned the Product Carbon Footprint Certification from the Carbon Trust. With this achievement, the company’s OLED panel…
NEW YORK, March 18, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Alphabet Inc. (NASDAQ: GOOG, GOOGL), the parent company of Google, between February 4, 2020 and January…
NEW YORK, March 18, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Hesai Group (NASDAQ: HSAI) resulting from allegations that Hesai may have issued materially misleading…
GUIYANG, Chine, 18 mars 2023 /PRNewswire/ — Un reportage de Huanqiu.com : Peu après 9h du matin, une salle de conférence du centre de données s’est vue remplie de participants. Zhang Xian, chef de projet du département de construction technique du Big Data Center de China Mobile…
CTA-werkzaamheden op schema om goedkeuring te verkrijgen voor de start van Fase 1 klinische studie van LMNL6511 in de tweede helft van 2023 Toevoeging van GPR40 agonist ontdekkingsprogramma gericht op de ontwikkeling van een nieuwe leverveilige GPR40 agonist voor de behandeling van type 2…
Les travaux de validation de la demande d’essai clinique sont en bonne voie pour obtenir l’autorisation de commencer l’essai clinique de phase 1 du LMNL6511 au cours du second semestre 2023 Ajout d’un programme de découverte d’agonistes GPR40 visant à développer un nouvel agoniste GPR40…